SS Innovations International Inc. has unveiled its Mobile Tele-Surgical Unit, aimed at improving remote surgical access and healthcare delivery in India.

The SSI MantraM is touted as a first-of-its-kind innovation designed to transform India’s robotic surgery and telemedicine landscape. The mobile tele-surgical unit reflects SS Innovations’ commitment to advancing medical technology, redefining healthcare infrastructure, and expanding access to cutting-edge surgical care, according to the company. The SSI MantraM’s introduction enables SS Innovations to expand the boundaries of med-tech, revolutionize surgical infrastructure, and secure India’s position as a global leader in robotic surgery and healthtech innovation.

“SSI MantraM is more than a mobile tele-surgical unit, it is an innovative step in the democratization and decentralization of the provision of world-class healthcare,” SS Innovations Founder/Chairman Dr. Sudhir Srivastava said. “With high-speed telecommunication and satellite connectivity, the SSI MantraM is designed to break geographical barriers, by delivering life-saving robotic-assisted surgery to underserved communities. Beyond tele-surgical procedures, SSI MantraM serves as a platform for surgical education, tele-mentoring, and real-time patient data analytics. With continuous research and innovation, SSI believes the company is taking a major step toward ensuring that advanced robotic surgery reaches those who need it most.”

Equipped with state-of-the-art telesurgery capabilities, SSI MantraM delivers high-quality robotic-assisted procedures to remote and underserved regions. The Tele-Sync Mobile Unit seamlessly integrates the company’s SSi Mantra 3 Surgical Robotic System, high-speed connectivity, and advanced surgical robotics to enable real-time collaboration between remote and on-site surgical teams. This innovation empowers expert surgeons to perform and guide procedures with minimal latency, making advanced surgical care more accessible than ever.

Related: SS Innovations Extends its Robotic Capabilities to Indonesia

“Congratulations to SSI for making history by igniting the next revolution in robotic surgery. [This] marks the beginning of an exciting new era, with SSI at the forefront of a transformation that will redefine the medical field,” theoretical physicist and futurist Dr. Michio Kaku stated. “When historians look back, they will recognize that this moment set into motion a movement that will reverberate across the world, redefining the way surgery is performed. But this is only the beginning. We are witnessing the dawn of the next phase that goes beyond where we stand today.”

“While this phase will shape the future for years to come, I can already see the emergence of something even greater: the integration of quantum mechanics into surgery. This will not just be robotic surgery; it will be quantum mechanical robotic surgery, an evolution that will once again revolutionize medicine,” Dr. Kaku continued. “Years from now, history will mark SSI as the epicenter of this transformation, the place where visionaries, driven by energy and foresight, propelled this revolution forward. I eagerly await the next great leap, where quantum mechanics and robotic surgery merge, opening yet another frontier in medical innovation.”

The SSi Mantra 3 Surgical Robotic System is marketed as the world’s only robotic system to have received regulatory approval for telesurgery and tele-proctoring. Approved by the Central Drugs Standard Control Organization (CDSCO), this validation opens the door to remote surgeries and medical education, enabling healthcare professionals to collaborate across great distances.

The SSi Mantra Surgical Robotic System is a modular multi-arm system with many advanced technology features. It allows for the use of three to five robotic arms, has an open-faced ergonomic Surgeon Command Centre, a 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are more than 40 different types of robotic endo-surgical instruments that can be used for different specialties including cardiac surgery. The learning curve for surgeons is shorter due to the SSi Mantra’s ergonomic design and user-friendly features.

The SSi Mantra has been clinically validated in India in more than 80 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving U.S. Food and Drug Administration and CE Mark approval in the second half of this year.

SS Innovations International Inc. develops surgical robotic technologies that aim to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. The company’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra,” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SS Innovations’ business operations are headquartered in India and the company plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally.